0001209191-23-043441.txt : 20230726
0001209191-23-043441.hdr.sgml : 20230726
20230726170555
ACCESSION NUMBER: 0001209191-23-043441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230724
FILED AS OF DATE: 20230726
DATE AS OF CHANGE: 20230726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirk Christopher J.
CENTRAL INDEX KEY: 0001744253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 231114345
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-24
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001744253
Kirk Christopher J.
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Stock Option (right to buy)
22.85
2023-07-24
4
D
0
87500
D
2029-01-05
Common Stock
87500
0
D
Stock Option (right to buy)
2.28
2023-07-24
4
A
0
87500
A
2029-01-05
Common Stock
87500
87500
D
Stock Option (right to buy)
3.29
2023-07-24
4
D
0
125000
D
2030-01-11
Common Stock
125000
0
D
Stock Option (right to buy)
2.28
2023-07-24
4
A
0
125000
A
2030-01-11
Common Stock
125000
125000
D
Stock Option (right to buy)
5.45
2023-07-24
4
D
0
260000
D
2031-01-07
Common Stock
260000
0
D
Stock Option (right to buy)
2.28
2023-07-24
4
A
0
260000
A
2031-01-07
Common Stock
260000
260000
D
Stock Option (right to buy)
14.55
2023-07-24
4
D
0
170000
D
2032-01-04
Common Stock
170000
0
D
Stock Option (right to buy)
2.28
2023-07-24
4
A
0
170000
A
2032-01-04
Common Stock
170000
170000
D
Stock Option (right to buy)
6.84
2023-07-24
4
D
0
190000
D
2033-01-07
Common Stock
190000
0
D
Stock Option (right to buy)
2.28
2023-07-24
4
A
0
190000
A
2033-01-07
Common Stock
190000
190000
D
Fully vested and exercisable.
On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2020, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.
One forty-eighth (1/48th) of the shares vested or shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.
/s/ Marc Belsky, Attorney-in-Fact
2023-07-26